STOCK TITAN

Compounding Growth: Ingersoll Rand Adds to Durability of Business with Two Acquisitions

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Rhea-AI Summary
Ingersoll Rand (NYSE: IR) completes acquisitions of Controlled Fluidics and Ethafilter to enhance its life science and air treatment businesses. The acquisitions aim to boost market share, introduce new revenue streams, and expand into in-vitro diagnostics, genomics, and sterile filter technology markets. The company expects mid-teens return on invested capital by the third year of ownership.
Positive
  • None.
Negative
  • None.

From a market expansion perspective, the integration of Controlled Fluidics and Ethafilter into Ingersoll Rand's portfolio represents a strategic move to diversify and strengthen its position in the life science and air treatment markets. Controlled Fluidics brings specialized capabilities in high-performance plastic bonding and assembly, which are critical in medical and aerospace applications. This could potentially open up new client segments and boost Ingersoll Rand's market share in these niche areas.

Ethafilter, on the other hand, extends the company's reach in the compressed air sector with its filter technology. The aftermarket services and offerings associated with filters typically provide a steady revenue stream due to the recurring nature of filter replacements and maintenance services. This aligns with Ingersoll Rand's aim for ongoing growth and could positively influence the company's long-term revenue stability.

The expected mid-teens return on invested capital (ROIC) by the third full year post-acquisition is an ambitious target that signals confidence in the accretive nature of these acquisitions. However, investors should monitor the integration process closely as the realization of synergies and the actual impact on ROIC will depend on effective execution and market conditions.

When evaluating the financial implications of Ingersoll Rand's acquisitions, the focus on mid-teens ROIC is a significant benchmark. It suggests that management is confident in their ability to efficiently allocate capital towards profitable ventures. For stakeholders, this is a positive indicator of the company's financial discipline and strategic planning.

However, the integration costs and how they will be managed in the short term could impact financial results. Investors should consider the potential for initial dilution of earnings before the promised ROIC is realized. Additionally, the expansion into in-vitro diagnostics and genomics may require significant R&D and marketing investments to capture market share from established competitors in these fields.

It is also important to assess how these acquisitions align with Ingersoll Rand's overall business model and whether they can leverage existing sales channels and operational efficiencies to maximize the value of these new assets.

The acquisitions of Controlled Fluidics and Ethafilter are indicative of Ingersoll Rand's inorganic growth strategy, focusing on acquiring companies with complementary technologies. This approach can be quicker than organic growth in capturing market share and entering new markets.

However, the success of such M&A activities hinges on the seamless integration of the acquired entities. Cultural fit, technology integration and retention of key personnel are just as important as the financial aspects. It is imperative for Ingersoll Rand to ensure that the acquired companies' expertise and product lines are effectively integrated into their existing operations to avoid value erosion.

Additionally, entering the in-vitro diagnostics and genomics spaces is a forward-looking move, as these areas are expected to grow substantially. Yet, the level of competition and regulatory hurdles in these industries should not be underestimated. The company's commitment to capital allocation must be balanced with a cautious approach to navigating these complex markets.

  • Acquisitions complement Ingersoll Rand’s existing portfolio in the life science and air treatment businesses
  • Offer opportunities to grow market share with new revenue streams and access to new markets including in-vitro diagnostics, genomics, and sterile filter technology
  • Demonstrates company’s commitment to capital allocation and expected achievement of mid-teens return on invested capital (ROIC) by third full year of ownership

DAVIDSON, N.C.--(BUSINESS WIRE)-- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and industrial solutions, has closed on the acquisitions of Controlled Fluidics and Ethafilter s.r.l. (“Ethafilter”).

Controlled Fluidics, with two sites in the United States, specializes in thermoplastic, high-performance plastic bonding and custom plastic assembly products for life sciences, medical, aerospace, and industrial applications. The acquisition will complement Ingersoll Rand’s current life sciences offerings and increase the company’s market share in high-growth, sustainable end markets. The business will join the Precision and Science Technologies (P&ST) segment.

Based in Italy, Ethafilter primarily produces filters and filter elements that can be used with all major brands in the compressed air sector. The acquisition will expand Ingersoll Rand’s product portfolio, extend its reach in highly attractive end markets with the addition of sterile filter technology, and drive ongoing growth from aftermarket services and offerings. Ethafilter will join the Industrial Technologies and Services (IT&S) segment.

“The acquisitions of Controlled Fluidics and Ethafilter are the latest examples of our continued strategy to acquire adjacent technologies that will complement our core offerings and provide opportunities for growth,” said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. “We continue to compound our growth with strategic acquisitions that can ensure the durability of our business.”

About Ingersoll Rand Inc.

Ingersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to Making Life Better for our employees, customers, shareholders, and planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and industrial solutions. Supported by over 80+ respected brands, our products and services excel in the most complex and harsh conditions. Our employees develop customers for life through their daily commitment to expertise, productivity, and efficiency. For more information, visit www.IRCO.com.

Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to Ingersoll Rand Inc.’s (the “Company” or “Ingersoll Rand”) expectations regarding the performance of its business, its financial results, its liquidity and capital resources and other non-historical statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “on track to” “will continue,” “will likely result,” “guidance” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. All statements other than historical facts are forward-looking statements.

These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) adverse impact on our operations and financial performance due to natural disaster, catastrophe, global pandemics (including COVID-19), geopolitical tensions, cyber events or other events outside of our control; (2) unexpected costs, charges or expenses resulting from completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; and (11) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in its periodic filings with the SEC, which are available on the SEC’s website at http://www.sec.gov. The foregoing list of important factors is not exclusive.

Any forward-looking statements speak only as of the date of this release. Ingersoll Rand undertakes no obligation to update any forward-looking statements, whether as a result of new information or development, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.

Investor Relations:

Matthew.Fort@irco.com

Media:

Meghan.Agostinelli@irco.com

Source: Ingersoll Rand Inc.

Ingersoll Rand has closed the acquisitions of Controlled Fluidics and Ethafilter.

Controlled Fluidics specializes in thermoplastic, high-performance plastic bonding, and custom plastic assembly products for life sciences, medical, aerospace, and industrial applications.

Ethafilter is based in Italy.

Ethafilter primarily produces filters and filter elements for use with major brands in the compressed air sector.

Controlled Fluidics will join the Precision and Science Technologies (P&ST) segment, while Ethafilter will join the Industrial Technologies and Services (IT&S) segment.
Ingersoll-Rand Inc

NYSE:IR

IR Rankings

IR Latest News

IR Stock Data

Air and Gas Compressor Manufacturing
Manufacturing
Link
Industrial Conglomerates, Producer Manufacturing, Industrial Machinery, Manufacturing, Air and Gas Compressor Manufacturing
US
Davidson

About IR

ingersoll rand (nyse:ir) advances the quality of life by creating and sustaining safe, comfortable and efficient environments. our people and our family of brands-including club car®, ingersoll rand®, thermo king®, and trane® work together to enhance the quality and comfort of air in homes and buildings; transport and protect food and perishables; secure homes and commercial properties; and increase industrial productivity and efficiency. we are a global business committed to a world of sustainable progress and enduring results.